Latest period
198.10M
YoY change
+13.3%
5Y CAGR
+23.3%
Peak year (2025)
190.13M
Latest annual
190.13M
Shares Outstanding history chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: 190.13M
Shares Outstanding growth chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: +13.3%
Shares Outstanding history table for Revolution Medicines (RVMD) from 2017 to 2025
| 2025 | 190.13M | +13.3% | +22.39M | ||
| 2024 | 167.74M | +48.2% | +54.59M | ||
| 2023 | 113.15M | +40.3% | +32.52M | ||
| 2022 | 80.63M | +10.7% | +7.82M | ||
| 2021 | 72.81M | +9.3% | +6.21M | ||
| 2020 | 66.60M | +82.6% | +30.13M | ||
| 2019 | 36.47M | 0.0% | 0 | ||
| 2018 | 36.47M | 0.0% | 0 | ||
| 2017 | 36.47M | — | — |
- 2025190.13M+13.3%
- 2024167.74M+48.2%
- 2023113.15M+40.3%
- 202280.63M+10.7%
- 202172.81M+9.3%
- 202066.60M+82.6%
- 201936.47M0.0%
- 201836.47M0.0%
- 201736.47M—
Shares Outstanding values are taken from Revolution Medicines's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's latest reported diluted shares outstanding is 198.10M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual diluted shares outstanding for Revolution Medicines (RVMD) came in at 190.13M – grew 13.3% year-over-year.
Over 2020–2025 (5 years), Revolution Medicines diluted shares outstanding expanded at a +23.3% compound annual rate, sustaining 6 straight years of year-over-year growth.
The record annual diluted shares outstanding stands at 190.13M, reached in 2025; the historical low of 36.47M was recorded in 2017.
Revolution Medicines Shares Outstanding by Year
Revolution Medicines Shares Outstanding 2025: 190.13M
Revolution Medicines diluted shares outstanding in 2025 was 190.13M, grew 13.3% from 2024. This figure represents the highest annual value in the available history.
Revolution Medicines Shares Outstanding 2024: 167.74M
2024's diluted shares outstanding for Revolution Medicines came in at 167.74M, surged 48.2% from 2023.
Revolution Medicines Shares Outstanding 2023: 113.15M
Revolution Medicines posted diluted shares outstanding of 113.15M in 2023, surged 40.3% from 2022.
Revolution Medicines Shares Outstanding 2022: 80.63M
In 2022, Revolution Medicines reported diluted shares outstanding of 80.63M, grew 10.7% from 2021.
Revolution Medicines Shares Outstanding 2021: 72.81M
Revolution Medicines diluted shares outstanding in 2021 was 72.81M.
See more financial history for Revolution Medicines (RVMD).
Sector peers by Shares Outstanding
Healthcare peers of Revolution Medicines (RVMD), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Revolution Medicines (RVMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation